Genomics

Dataset Information

0

8c04ed0b-6517-42ab-b510-7a64e9f57129 - samples


ABSTRACT: We analyzed baseline and on-therapy tumor biopsies from 101 patients with advanced melanoma treated with nivolumab (anti-PD-1) alone or combined with ipilimumab (anti-CTLA-4). Analysis of whole transcriptome data showed that T cell infiltration and interferon-gamma signaling signatures corresponded most highly with clinical response to therapy, with a reciprocal decrease in cell cycle and WNT signaling pathways in responding biopsies. Clinical outcome differences were likely not due to differential melanoma cell responses to interferon-gamma, as 57 human melanoma cell lines exposed in vitro to this cytokine showed a conserved interferon-gamma transcriptome response unless they had mutations that precluded signaling from the interferon-gamma receptor. Therefore, the magnitude of the antitumor T cell response and the corresponding downstream interferon-gamma signaling are the main drivers of clinical response or resistance to immune checkpoint blockade therapy.

PROVIDER: EGAD00001006284 | EGA |

REPOSITORIES: EGA

Similar Datasets

| EGAS00001004545 | EGA
| EGAD00001006282 | EGA
2023-03-13 | GSE217162 | GEO
2022-04-21 | PXD033340 | Pride
2024-02-06 | GSE244983 | GEO
2024-02-06 | GSE244982 | GEO
2023-02-02 | PXD035347 | Pride
| PRJNA646456 | ENA
| PRJNA640390 | ENA
| phs001257 | dbGaP